DENTSPLY SIRONA Inc.is maintained at an average outperform rating by 16 stock analysts, and there are at least 1.77% of shares outstanding that are now legally short sold. 1 grew positions while 0 funds amassed positions. The hedge funds in our partner's database now hold: 412,640 shares, down from 812,996 shares in 2017Q3. West Oak Capital Limited Liability Co holds 22,294 shares or 0.9% of its portfolio. Dentsply Sirona's dividend payout ratio (DPR) is 13.16%. Clearbridge Investments LLC now owns 6,958,367 shares of the medical instruments supplier's stock valued at $458,069,000 after purchasing an additional 340,634 shares during the period. Gemmer Asset Management Lc has 252 shares. (NASDAQ:XRAY) for 5,897 shares.
Generation Investment Management Llp filed with SEC a SC 13G form for Dentsply Sirona Inc. It can be found at: 000117266118000966. David Blood And Al Gore's Generation Investment Management Llp now owns 5.2% of the Health Care- stock. Given the importance of identifying companies that will ensure earnings per share at a high rate, we later obsession to umpire how to determine which companies will achieve high amassing standards. Institutional ownership refers to the ownership stake in a company that is held by large financial organizations, pension funds or endowments.
Filings show 7 investors own Dentsply Sirona Inc.
Generation owned only 9 million shares of Dentsply at the end of 2017. This is increased by 423160.
Dentsply Sirona (NASDAQ:XRAY) last released its quarterly earnings data on Thursday, March 1st. Short-term as well long term investors always focus on the liquidity of the stocks so for that concern, liquidity measure in recent quarter results of the company was recorded 2.10 as current ratio and on the opponent side the debt to equity ratio was 0.25 and long-term debt to equity ratio also remained 0.24. Grandeur Peak Glob Ltd Llc has 1.70M shares.
According to the investigation by a law firm under ERISA employees of Sirona Dental Systems, Inc. The Company develops, manufactures, and markets solutions offering, including dental and oral health products, as well as other consumable medical devices. (NASDAQ:XRAY) advice adding it to buy candidate list.
We're not going to evaluate those companies on those criteria, but Barron's calculates that both stocks turned in respectable performances previous year. XRAY's profit will be $97.76M for 28.58 P/E if the $0.43 EPS becomes a reality. The DENTSPLY SIRONA Inc. has shown a five days performance of 0.69% and thirty days performance stands at -8.85%. Over the past 5 trading days, the stock has moved 0.49%. The stock's average target of $69.89 is 40.74% above today's ($49.66) share price.
ILLEGAL ACTIVITY WARNING: "Dentsply Sirona (NASDAQ:XRAY) Stock Rating Reaffirmed by Cleveland Research" was first posted by The Lincolnian Online and is the property of of The Lincolnian Online. It has underperformed by 17.57% the S&P500. The company has a market cap of $11,145.58, a P/E ratio of 18.43, a price-to-earnings-growth ratio of 2.14 and a beta of 1.26. It operates through four divisions: Consulting Services Â- Canada, Consulting Services Â- United States, Consulting Services Â- Global, and Construction Services. It now has negative earnings. The firm provides dental consumable products, including endodontic instruments and materials, dental anesthetics, prophylaxis pastes, dental sealants, impression materials, restorative materials, tooth whiteners, and topical fluoride products; and small equipment products comprising dental hand pieces, intraoral curing light systems, dental diagnostic systems, and ultrasonic scalers and polishers.
Among 6 analysts covering Stantec (NYSE:STN), 3 have Buy rating, 0 Sell and 3 Hold. The positive are 73%. Dentsply Sirona has a fifty-two week low of $48.25 and a fifty-two week high of $68.98.
Currently, the stock carries a price to earnings ratio of 4.19, a price to book ratio of 1.34, and a price to sales ratio of 1.64. On Thursday, November 9 the rating was maintained by Jefferies with "Buy".
In other DENTSPLY SIRONA news, CEO James G. Mosch sold 50,600 shares of the business's stock in a transaction dated Monday, April 24th. The company was upgraded on Monday, November 6 by Barrington Research. Finally, HC Wainwright set a $63.00 price objective on Dentsply Sirona and gave the stock a "hold" rating in a research report on Monday, March 5th. The firm earned "Outperform" rating on Wednesday, August 17 by National Bank Canada. DA Davidson downgraded the stock to "Neutral" rating in Thursday, April 14 report.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.
Of 'Deadpool 2' Introduces His X-Force Pals
I like sports and grilling on my deck", offered a few details on each X-Force character. " Domino said she's really lucky". Zeitgeist was created by Peter Milligan and artist Mike Allred and first appeared in "X-Force #116".